Related Experiment Video
Updated: Sep 21, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Cost-effectiveness of CT perfusion for patients with acute ischemic stroke (CLEOPATRA)-Study protocol for a
Miou S Koopman1, Jan W Hoving1, Henk van Voorst1,2
1Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Insights
This study estimates the costs and health effects of using computed tomography perfusion (CTP) to select patients with acute ischemic stroke (AIS) for endovascular thrombectomy (EVT). Results will inform CTP
Area of Science:
- Health economics and outcomes research in neurovascular interventions.
- Medical imaging and artificial intelligence in acute stroke management.
- Clinical trial data analysis and health technology assessment.
Background:
- Computed tomography perfusion (CTP) is used for endovascular thrombectomy (EVT) selection in acute ischemic stroke (AIS), but its role in the early (0-6h) window is debated.
- The costs and health effects of incorporating CTP into EVT selection protocols, especially in the early time window, are not well understood.
- Current guidelines recommend CTP for later time windows (6-24h) but not for earlier ones, creating uncertainty in clinical practice.
Purpose of the Study:
- To estimate the costs and health effects associated with using CTP for EVT selection in AIS patients.
- To compare CTP-based selection versus conventional selection strategies for EVT in AIS patients.
- To provide data for developing recommendations on CTP use in AIS EVT selection across different time windows (0-24h).
Main Methods:
- The CLEOPATRA study utilizes clinical and imaging data from prospective EVT trials and registries.
- A Markov health state transition model simulates clinical outcomes over a 5-year period for CTP-based and conventional EVT selection.
- The analysis incorporates data on event probabilities, costs, and Quality-Adjusted Life Years (QALYs) per modified Rankin Scale (mRS) subscore.
Main Results:
- The primary outcome is the Incremental Cost-Effectiveness Ratio (ICER) per QALY gained over the 5-year simulation.
- Cumulative outcome measures will be reported over the 5-year follow-up period.
- The study provides preliminary insights into the cost-effectiveness of CTP for EVT selection in AIS.
Conclusions:
- This research offers preliminary data on the economic and clinical value of CTP in EVT selection for AIS patients.
- The findings aim to inform future clinical guidelines and implementation strategies for CTP use.
- Understanding the cost-effectiveness of CTP can guide healthcare resource allocation for stroke interventions.
Introduction:
Computed tomography perfusion (CTP) is variably considered to assess eligibility for endovascular thrombectomy (EVT) in acute ischemic (AIS) stroke patients. Although CTP is recommended for patient selection in later (6-24 h) time window, it is currently not recommended in the earlier (0-6 h) time window and the costs and health effects of including CTP for EVT selection remain unknown. We aim to estimate the costs and health effects of using CTP for EVT selection in AIS patients compared to conventional selection.
Patients And Methods:
CLEOPATRA is a healthcare evaluation study using clinical and imaging data from multiple, prospective EVT trials and registries in both the earlier and later time windows. To study the long-term health and cost effects, we will construct a ("Markov") health state transition model simulating the clinical outcome over a 5-year follow-up period for CTP-based and conventional selection for EVT. Clinical data acquired within the current study and estimates from the literature will be used as input for probabilities of events, costs, and Quality-Adjusted Life Years (QALYs) per modified Rankin Scale (mRS) subscore. Primary outcome for the cost-effectiveness analysis will be the Incremental Cost-Effectiveness Ratio (ICER) in terms of costs per QALY gained over the simulated follow-up period.
Study Outcomes:
Outcome measures will be reported as cumulative values over a 5-year follow-up period.
Discussion:
This study will provide preliminary insight into costs and health effects of including CTP in the selection for EVT for AIS patients, presenting between 0 and 24 h after time last known well. The results may be used to develop recommendations and inform further implementation projects and studies.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...

